Chicago Partners Investment Group LLC Increases Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Chicago Partners Investment Group LLC has significantly increased its investment in the iShares Biotechnology ETF (NASDAQ:IBB) by 45.8% during the third quarter. This increase was disclosed in the firm’s latest Form 13F filing to the Securities and Exchange Commission. After this boost, the group now holds a total of 3,689 shares of the ETF, having acquired an additional 1,159 shares during this reporting period. At the close of the most recent quarter, these holdings were valued at approximately $524,000.

Other institutional investors have also been adjusting their positions in the iShares Biotechnology ETF. Highline Wealth Partners LLC established a new investment in the ETF, valued at around $30,000 during the third quarter. Similarly, Bbjs Financial Advisors LLC also made a new purchase in the second quarter, amounting to about $31,000. Voisard Asset Management Group Inc. acquired shares worth about $59,000 in the third quarter, while Chris Bulman Inc. bought approximately $64,000 worth of shares in the second quarter. Lastly, Eastern Bank expanded its holdings with a new position in the third quarter valued at around $65,000. Overall, institutional investors now hold a substantial 62.45% of the ETF's stock.

Current Stock Performance of iShares Biotechnology ETF

As of Tuesday, shares of the iShares Biotechnology ETF (NASDAQ:IBB) opened at $142.85. The ETF has a 50-day moving average of $145.02 and a 200-day moving average of $140.57. Over the past year, the ETF reached a low of $113.56 and a high of $150.57.

Recent Dividend Announcement for iShares Biotechnology ETF

The iShares Biotechnology ETF recently announced a dividend that was paid on September 30th. Investors who were on record as of September 25th received a dividend of $0.2005 per share, with the ex-dividend date also being September 25th.

About the iShares Biotechnology ETF

The iShares Nasdaq Biotechnology ETF, formerly known as the iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund designed to track the performance of the NASDAQ Biotechnology Index. This index includes stocks of NASDAQ-listed companies that are classified within the biotechnology or pharmaceutical sectors and meet other specified criteria set by NASDAQ.

Investments, ETFs, Biotechnology